| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/09/2004 | US6703413 Production of apoptotic films for direct contact with tumors |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703409 Nitrogen compounds such as 2'-chloro-3',5'-dimethoxyphen-1'-yl -imino-2-imidazolidine or isomers, used as preferential adrenoceptor agonists for prevention of incontinence; side effect reduction |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703212 Involves incubating a blood sample with a fluorescent probe that interacts with protein kinase c (pkc) or protein kinase a (pka), and measuring the fluorescence intensity in different conditions |
| 03/09/2004 | US6703042 Salts of L-carnitine and lower alkanoyl L-carnitine |
| 03/04/2004 | WO2004005264A3 Imidazole compounds for the treatment of hepatitis c virus infections |
| 03/04/2004 | WO2004004462B1 Biocidal composition containing halogenated hydantoin and paraffin wax |
| 03/04/2004 | WO2004001059A3 Heterocyclic inhibitors of kinases |
| 03/04/2004 | WO2003088917A3 Regulation of tnf-alpha |
| 03/04/2004 | WO2003082216A9 Neuroprotectant methods, compositions, and screening methods thereof |
| 03/04/2004 | WO2003004464A8 Heterocyclic amide derivatives and the use thereof as pesticides |
| 03/04/2004 | WO2002070469A3 Selective pde3b inhibitors and use of the same in therapy |
| 03/04/2004 | US20040044081 Hypotensive agents; cardiovascular disorders; anticholesterol agents; antiarrhythmia agents |
| 03/04/2004 | US20040044062 Method of treatment of viral infection including HIV using water soluble fullerenes - III |
| 03/04/2004 | US20040044059 Tubulin binding ligands and corresponding prodrug constructs |
| 03/04/2004 | US20040044057 5- substituted tetralones as inhibitors of ras farnesyl trransferase |
| 03/04/2004 | US20040044049 Compounds for inhibiting insulin secretion and methods related thereto |
| 03/04/2004 | US20040044047 Alpha and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 03/04/2004 | US20040044037 Sleep disorders; antidepressants; analgesics; central nervous system disorders |
| 03/04/2004 | US20040044008 Dietetics; antilipemic agents; non-insulin dependent diabetes; cardiovascular disorders |
| 03/04/2004 | US20040043988 Cycloalkyl alkanoic acids as intergrin receptor antagonists |
| 03/04/2004 | US20040043969 Tubulin binding agents and corresponding prodrug constructs |
| 03/04/2004 | US20040043393 AXOR35, a G-protein coupled receptor |
| 03/04/2004 | US20040040840 Controller for redox system |
| 03/04/2004 | DE10238742A1 New N-(maleimidyl- or thiohydantoinyl-alkyl)-piperazine derivatives, are androgen receptor destabilizers and/or inhibitors useful e.g. for treating prostate carcinoma or hyperplasia |
| 03/04/2004 | DE10238212A1 Verfahren zur Herstellung von α-Aminosäuren durch Hydrolyse von Hydantoinen bei erhöhtem Druck und erhöhter Temperatur Process for the preparation of α-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature |
| 03/03/2004 | EP1394243A1 Cyclic aminothioureas as additives for lubricating oils |
| 03/03/2004 | EP1394242A2 Cyclic thioureas and their use as additives for lubricating oils |
| 03/03/2004 | EP1394238A1 Cyclic nitroxyl compounds as additives for lubricating oils |
| 03/03/2004 | EP1394162A1 Intermediates of azole antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1394152A1 2-iminoimidazole derivatives (1) |
| 03/03/2004 | EP1394151A1 Preventives/ remedies for complications of diabetes |
| 03/03/2004 | EP1394148A1 Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated presssure and elevated temperature |
| 03/03/2004 | EP1394142A1 Carboxylic acid intermediates of antifungal agents and processes for the preparation thereof |
| 03/03/2004 | EP1392660A1 Substituted benzoylcyclohexenones and their use as herbicidal agents |
| 03/03/2004 | EP1392655A2 Potassium channel openers |
| 03/03/2004 | EP1392639A1 Pyruvate derivatives |
| 03/03/2004 | EP1392637A2 Modulators of peroxisome proliferator activated receptors |
| 03/03/2004 | EP1392317A2 Substituted 1-benzazepines and derivatives thereof |
| 03/03/2004 | EP1392315A1 Methods of treating alzheimer's disease |
| 03/03/2004 | EP1392291A2 Tripeptidyl peptidase inhibitors |
| 03/03/2004 | EP1392280A2 Arylsulfonamide ethers, and methods of use thereof |
| 03/03/2004 | EP1392246A1 Compaction process for manufacture of sodium phenytoin dosage form |
| 03/03/2004 | EP1097140B1 Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them |
| 03/03/2004 | EP1007039B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 03/03/2004 | EP0986386B1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases |
| 03/03/2004 | EP0932602B1 Bases of cationic oxidation, their use for oxidative dyeing of keratin fibres, dye compositions and dyeing processes |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479704A Method for producing molecular compound |
| 03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699909 Aminoindanes |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699873 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 03/02/2004 | US6699647 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms |
| 02/26/2004 | WO2004016631A1 Phosphonium and imidazolium salts and methods of their preparation |
| 02/26/2004 | WO2004016570A2 Ionic liquids containing a sulfonate anion |
| 02/26/2004 | WO2004016216A2 Imidazole alkaloids from lepidium meyenii and methods of usage |
| 02/26/2004 | WO2004016086A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 02/26/2004 | WO2003094854A3 Succinoyl aminopyrazoles and related compounds |
| 02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 02/26/2004 | WO2003057144A3 Change inhibitors of dipeptidyl peptidase iv |
| 02/26/2004 | WO2003056299A3 Labeling reagent and methods of use |
| 02/26/2004 | WO2003050261A3 (1-phenyl-2-heteroaryl)ethyl-guanidine compounds as inhibitors of mitochondrial f1f0 atp hydrolase |
| 02/26/2004 | WO2002083067A9 Prodrugs via acylation with cinnamate |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | US20040039228 Process for the preparation of alpha-amino acids by hydrolysis of hydantoins at elevated pressure and elevated temperature |
| 02/26/2004 | US20040039210 Process for preparation of n-substituted 2-sulfanylimidazoles |
| 02/26/2004 | US20040039041 Using an alfa2-adrenoceptor antagonist or an ester or salt selected from atipamezole, idazoxan, efaroxan or their salts, to prevent dyskinesias caused by chronic use of dopaminergic agents while treting neuropsychiatric disorders |
| 02/26/2004 | US20040039040 Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient |
| 02/26/2004 | US20040039033 Administering (1-phenyl-2-heteroaryl)ethyl-guanidine compounds for treating ischemic conditions including myocardial infarction, congestive heart failure, and cardiac arrhythmias |
| 02/26/2004 | US20040038991 Imidazolyl-cyclic acetals |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules |
| 02/26/2004 | DE10236868A1 New (hetero)aryl-substituted carboxamide compounds, are factor Xa and factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or tumors |
| 02/26/2004 | CA2495384A1 Ionic liquids containing a sulfonate anion |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | EP0688210B1 Use of carnosine in combination with urocanic acid for treatment of photodermatoses |
| 02/25/2004 | CN1478080A Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1477101A Purification method of Ganbaosu |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696475 Substituted phenyl derivatives, their preparation and use |
| 02/24/2004 | US6696456 Carbocyclic acids and salts such as (2s,3r)-3-ethylsulfanyl-2-(4'-fluoro-biphenyl-4-sulfonylamino)-3- phenylpropionic acid, used as metalloenzyme antagonists for the prophylaxis of degenerative joint disease and as wound healing agents |